jacktrader did u see latest ann int?, page-2

Here you go-

Regulatory Announcement
Go to market news section View chart
Company International Medical Devices PLC
TIDM INT
Headline Re Alliance
Released 07:02 01-Feb-06
Number 7223X











International Medical Devices starts safe needle trials with NHS





International Medical Devices (IMD or ‘the Company’) is pleased to announce that its range of safe needles and syringes is to undergo clinical tests with the National Health Service with delivery of supplies into the NHS scheduled to follow immediately. Marketing of the devices is being conducted by IMD’s wholly-owned subsidiary Meddis Ltd which is an existing approved supplier to the NHS.



A number of retractable and novel safe devices are being tested. IMD is confident that its products will meet the NHS’s needs both in terms of quality, clinical efficiency and price. Until now the cost of so-called safe devices has been a prohibitive factor for health authorities but all products offered by IMD will be at a small premium over conventional needles currently used and will undercut existing devices from other manufacturers.

Needlestick accidents are the second biggest cause of injuries to health workers in both the NHS and private sectors. There are 40,000 reported needlestick accidents a year in the UK and it is thought as many again go unreported.

They account for 17 per cent of accidents to NHS staff. Contaminated needles can transmit more than 20 dangerous blood-borne pathogens including hepatitis B and C and HIV. According to the NHS at least four healthcare workers have died following occupationally acquired HIV infection*. Recent cases, including one brought by Unison against the Scottish NHS, have highlighted the need for the widespread use of safe devices.

The NHS is keen to see widespread use of safety devices for all its “frontline” staff before expected legislation is introduced to make safe needles compulsory.

* The Management of Health, Safety and Welfare Issues. NHS 2005

About IMD:

International Medical Devices plc was founded to exploit opportunities in the medical devices market, initially in the UK and Europe. It was admitted to AIM on November 10, 2004 and in July it acquired a range of technology patents, including those covering safe needles, from Eastland Technology Australia Ltd and distribution rights from Eastland Medical Systems Ltd. In September the Company acquired the entire share capital of Meddis Ltd, a distributor of acute care medical devices.

www.imd-plc.com

Further information:

Chris Thomas, IMD: 0207 659 5216

Alan Frame, Westport Communications: 0207 405 7777 or 07850 944187